ガンにおけるTIGIT: 作用機構から有望な免疫療法戦略へ
Haozhe Cui1, Mawieh Hamad2, Eyad Elkord3,4
1Department of Biosciences and Bioinformatics & Suzhou Municipal Key Lab of Biomedical Sciences and Translational Immunology, School of Science, Xi'an Jiaotong-Liverpool University, Suzhou, Jiangsu, China.
Cell death & disease
|September 1, 2025
まとめ
TIGIT免疫チェックポイントはT細胞とNK細胞の活動を抑制する. 臨床試験における抗TIGIT抗体単体療法の限界のために,新しい組み合わせの治療法と代替アプローチが検討されています.
科学分野:
- 免疫学
- 癌 生物学
- 薬物開発
背景:
- TIGIT (IgとITIMドメインを持つT細胞免疫受容体) は免疫チェックポイントタンパク質です.
- 様々なメカニズムでT細胞とNK細胞の細胞毒機能を抑制する.
- TIGITはPVRのようなタンパク質ファミリーに属し,CD155と相互作用する.
研究 の 目的:
- TIGITによる免疫抑制のメカニズムを見直す
- TIGITを標的とした新興の免疫療法戦略について議論する.
- 現在の臨床試験とTIGITベースの治療法の将来の方向性を概説する.
主な方法:
- TIGITの機能と治療戦略に関する文献レビュー
- 抗TIGIT治療の臨床前および臨床試験データの分析
- モノクローナル抗体以外の代替アプローチの検討
主要な成果:
- TIGITは,T細胞とNK細胞の活動を抑制することで,抗腫瘍免疫を抑制する.
- TIGITに対するモノクローナル抗体の単独治療は,限られた臨床効果を示した.
- 小分子阻害剤や CAR-T細胞のような 組み合わせた治療法や 代替戦略は有望です
結論:
- TIGITの複雑な抑制メカニズムを理解することは極めて重要です.
- TIGITを標的とした 組み合わせ免疫療法が 癌治療の有望な道を示しています
- 現在の限界を克服するために,代替のTIGITターゲティング戦略に関するさらなる研究が必要である.
関連する概念動画
Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Cytotoxic T Cells-mediated Immune Response
1.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K


